Dr. Mirjam Mol-Arts has an extensive career in the pharmaceutical industry, most recently as former Chief Science & Medical Officer at Ferring Pharmaceuticals. Prior to that she served from 2014 till 2018 as CEO of the Pivot Park in Oss, the Netherlands. She has worked as VP Medical Affairs within Organon NV, Schering-Plough and Clinical Development Director Merck/MSD in women’s health and endocrinology. Currently dr. Mol-Arts is a Supervisory Board Member of Organon, Lygature and Holland PTC.